Grupo Profármaco
Select Site

You are in:

Group companies > Profármaco

Profármaco, S.A.

Flecha Arriba
Felcha abajo
Boton para Drag

This is the company in the group that carries out tasks such as Regulatory Affairs, Market Research and, above all, Promotion of our laboratories’ pharmaceutical products to physicians, pharmacies, hospitals and government institutions.

Its headquarters are located in Barcelona (Spain) and it has subsidiaries (Mefasa) in the seven countries of Central America and the Dominican Republic.

Executive team:

Eduard Pardo i Barris

Eduard Pardo i Barris

CEO

email
Miquel Simó

Miquel Simó

Administration, Finances and Managing Director

email
Peggy Vilarrubís

Peggy Vilarrubís

Marketing Director and Assistant to the Business Development Management

email
Elia Martínez Midence

Elia Martínez Midence

Legal Consultancy Manager and Regulatory Affairs Manager. Member of Sales Plans Dept

email
Mónica Flo

Mónica Flo

Administration Manager

email
Giancarlo Reyna

Giancarlo Reyna

Treasury Manager

email
Susana Puig

Susana Puig

Technology Division Director

email
Lidia Asencio

Lidia Asencio

Statistics Dept. / Assist. CEO

email
Carolina Puig

Carolina Puig

ICT Dept.

email
Anna Hernández

Anna Hernández

Invoicing Dept.

email
Estela Rodríguez

Estela Rodríguez

Logistics Dept. / Administration

email
Omar de León

Omar de León

Marketing Brand Manager Mefasa Farma

Profármaco, S.A. draws up sales plans in collaboration with the marketing departments of the laboratories it works with. It also selects, hires, trains, motivates, manages and controls separate sales rep teams for each country, manages and controls local distribution through its own subsidiaries and/or third-party distributors, and also proposes and sets local sales prices, manages and controls promotion and sales and, in general, safeguards the global interests of the laboratories it represents on each market.

Furthermore, Profármaco, S.A. has a growing licensed product portfolio for promotion and distribution in the Central American and Caribbean region, under its own pharmaceutical line called Mefasa Farma.